Scott A Holmes - Net Worth and Insider Trading

Scott A Holmes Net Worth

The estimated net worth of Scott A Holmes is at least $1 Million dollars as of 2024-04-18. Scott A Holmes is the SVP, Finance and Treasurer of AMAG Pharmaceuticals Inc and owns about 51,958 shares of AMAG Pharmaceuticals Inc (AMAG) stock worth over $714,423. Scott A Holmes is also the CFO of Keryx Biopharmaceuticals Inc and owns about 162,956 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $547,532. Details can be seen in Scott A Holmes's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott A Holmes has not made any transactions after 2018-11-15 and currently still holds the listed stock(s).

Transaction Summary of Scott A Holmes

To

Scott A Holmes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott A Holmes owns 2 companies in total, including Keryx Biopharmaceuticals Inc () , and AMAG Pharmaceuticals Inc () .

Click here to see the complete history of Scott A Holmes’s form 4 insider trades.

Insider Ownership Summary of Scott A Holmes

Ticker Comapny Transaction Date Type of Owner
Keryx Biopharmaceuticals Inc 2018-12-12 Chief Financial Officer
AMAG Pharmaceuticals Inc 2015-06-15 SVP & Finance and Treasurer

Scott A Holmes Latest Holdings Summary

Scott A Holmes currently owns a total of 2 stocks. Among these stocks, Scott A Holmes owns 51,958 shares of AMAG Pharmaceuticals Inc (AMAG) as of June 15, 2015, with a value of $714,423 and a weighting of 56.61%. Scott A Holmes also owns 162,956 shares of Keryx Biopharmaceuticals Inc (KERX) as of November 15, 2018, with a value of $547,532 and a weighting of 43.39%.

Latest Holdings of Scott A Holmes

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMAG AMAG Pharmaceuticals Inc 2015-06-15 51,958 13.75 714,423
KERX Keryx Biopharmaceuticals Inc 2018-11-15 162,956 3.36 547,532

Holding Weightings of Scott A Holmes


Scott A Holmes Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott A Holmes has made a total of 0 transactions in AMAG Pharmaceuticals Inc (AMAG) over the past 5 years. The most-recent trade in AMAG Pharmaceuticals Inc is the sale of 7,580 shares on June 15, 2015, which brought Scott A Holmes around $505,055.

According to the SEC Form 4 filings, Scott A Holmes has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 1,155 shares on November 15, 2018, which brought Scott A Holmes around $3,199.

Insider Trading History of Scott A Holmes

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott A Holmes Trading Performance

GuruFocus tracks the stock performance after each of Scott A Holmes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott A Holmes is -22.5%. GuruFocus also compares Scott A Holmes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott A Holmes within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Scott A Holmes's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Scott A Holmes

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -17.16 -22.5 -20.02 -19.22 7.35 -17.81
Relative Return to S&P 500(%) -16.8 -21.05 -17.46 -24.22 -3.62 -28.94

Scott A Holmes Ownership Network

Ownership Network List of Scott A Holmes

No Data

Ownership Network Relation of Scott A Holmes


Scott A Holmes Owned Company Details

What does Keryx Biopharmaceuticals Inc do?

Who are the key executives at Keryx Biopharmaceuticals Inc?

Scott A Holmes is the Chief Financial Officer of Keryx Biopharmaceuticals Inc. Other key executives at Keryx Biopharmaceuticals Inc include director & Interim CEO Jodie Pope Morrison , 10 percent owner Seth A Klarman , and director & 10 percent owner Baupost Group Llc/ma .

Keryx Biopharmaceuticals Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Keryx Biopharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Keryx Biopharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Keryx Biopharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Keryx Biopharmaceuticals Inc Insider Transactions

No Available Data

Scott A Holmes Mailing Address

Above is the net worth, insider trading, and ownership report for Scott A Holmes. You might contact Scott A Holmes via mailing address: C/o Keryx Biopharmaceuticals Inc 1 Marina Park Dr., 10th Floor Boston Ma 02210.

Discussions on Scott A Holmes

No discussions yet.